ampicillin has been researched along with cefiderocol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brönstrup, M; Grunenberg, J; Hotop, SK; Karge, B; Lai, YH; Peukert, C; Pinkert, L; Schulze, LM | 1 |
| Echols, R; Gill, CM; Longshaw, C; Nicolau, DP; Santini, D; Takemura, M; Yamano, Y | 1 |
2 other study(ies) available for ampicillin and cefiderocol
| Article | Year |
|---|---|
Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens.
Topics: Anti-Bacterial Agents; Benzamides; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxybenzoates; Microbial Sensitivity Tests; Molecular Structure; Siderophores; Structure-Activity Relationship | 2021 |
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Ampicillin; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cefiderocol; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Meropenem; Mice; Microbial Sensitivity Tests; Sulbactam | 2023 |